These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1545566)

  • 1. Characterization of growth inhibitory factors for mouse monocytic leukemia cells.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M; Matsuda T; Hirano T
    Leuk Res; 1992; 16(2):139-44. PubMed ID: 1545566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells.
    Ikuta T; Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M
    Cancer Immunol Immunother; 1989; 30(3):139-44. PubMed ID: 2480847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition.
    Abdollahi A; Lord KA; Hoffman-Liebermann B; Liebermann DA
    Cell Growth Differ; 1991 Aug; 2(8):401-7. PubMed ID: 1793735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein factors that regulate the growth and differentiation of mouse myeloid leukaemia cells.
    Hozumi M; Tomida M; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Honma Y; Hayashi M
    Ciba Found Symp; 1990; 148():25-33; discussion 33-42. PubMed ID: 2180647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 4 potentiates the antiproliferative effect of 1 alpha, 25-dihydroxyvitamin D3 on mouse monocytic leukemia cells but antagonizes the antiproliferative effects of interferon alpha, beta and interleukin 6.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    Leuk Res; 1992 Dec; 16(12):1191-6. PubMed ID: 1465028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    FEBS Lett; 1991 Oct; 291(2):181-4. PubMed ID: 1936261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
    Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
    Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effect of IFN-gamma and IFN-alpha/beta on differentiation of some clones of mouse myeloid leukemic cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M
    Leuk Res; 1989; 13(3):253-7. PubMed ID: 2496278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a factor inducing differentiation of mouse myeloid leukemic cells purified from conditioned medium of mouse Ehrlich ascites tumor cells.
    Tomida M; Yamamoto-Yamaguchi Y; Hozumi M
    FEBS Lett; 1984 Dec; 178(2):291-6. PubMed ID: 6210214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of mouse macrophage-like sublines that differ in leukemogenic potential and characterization.
    Kasukabe T; Honma Y; Hozumi M
    J Cell Physiol; 1984 Feb; 118(2):105-12. PubMed ID: 6582065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation by differentiation-stimulating factor/leukemia inhibitory factor of the survival time of mice implanted with mouse myeloid leukemia cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M
    Leuk Res; 1992 Oct; 16(10):1025-9. PubMed ID: 1405704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
    Matsuda T; Hirano T; Kishimoto T
    Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.
    Onozaki K; Akiyama Y; Okano A; Hirano T; Kishimoto T; Hashimoto T; Yoshizawa K; Taniyama T
    Cancer Res; 1989 Jul; 49(13):3602-7. PubMed ID: 2786454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
    Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
    Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative.
    Melamed D; Resnitzky D; Haimov I; Levy N; Pfarr CM; Yaniv M; Kimchi A
    Cell Growth Differ; 1993 Aug; 4(8):689-97. PubMed ID: 8398910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.